Search

Your search keyword '"Tokhanbigli, Samaneh"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Tokhanbigli, Samaneh" Remove constraint Author: "Tokhanbigli, Samaneh"
38 results on '"Tokhanbigli, Samaneh"'

Search Results

9. SARS-CoV-2 Non-structural protein 1(NSP1) mutation virulence and natural selection:Evolutionary trends in the six continents

14. Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models.

16. SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents

18. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends

19. Mutations in SARS-CoV-2 structural proteins:a global analysis

22. SARS-CoV-2 NSP3, NSP4 and NSP6 mutations and Epistasis during the pandemic in the world: Evolutionary Trends and Natural Selections in Six Continents

25. SARS‐CoV‐2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents

26. The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis.

27. Immunoregulatory impact of human mesenchymal-conditioned media and mesenchymal derived exosomes on monocytes

28. Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer

30. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis

31. Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride

32. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow

34. Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells.

35. Exosomes as a novel cell‐free therapeutic approach in gastrointestinal diseases.

36. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer.

37. SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents.

38. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends.

Catalog

Books, media, physical & digital resources